These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10092690

  • 1. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.
    Guite HF, Dundas R, Burney PG.
    Thorax; 1999 Apr; 54(4):301-7. PubMed ID: 10092690
    [Abstract] [Full Text] [Related]

  • 2. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease.
    Sin DD, Tu JV.
    Thorax; 2000 Mar; 55(3):194-7. PubMed ID: 10679537
    [Abstract] [Full Text] [Related]

  • 3. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.
    Meier CR, Jick H.
    Thorax; 1997 Jul; 52(7):612-7. PubMed ID: 9246132
    [Abstract] [Full Text] [Related]

  • 4. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
    Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB.
    Ann Intern Med; 2008 Sep 16; 149(6):380-90. PubMed ID: 18794557
    [Abstract] [Full Text] [Related]

  • 5. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
    Ringbaek T, Viskum K.
    Respir Med; 2003 Mar 16; 97(3):264-72. PubMed ID: 12645834
    [Abstract] [Full Text] [Related]

  • 6. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
    Rodrigo GJ, Rodrigo C.
    Am J Respir Crit Care Med; 2000 Jun 16; 161(6):1862-8. PubMed ID: 10852758
    [Abstract] [Full Text] [Related]

  • 7. Ipratropium treatment of acute airways disease.
    Peterson GM, Boyles PJ, Bleasel MD, Vial JH.
    Ann Pharmacother; 2003 Mar 16; 37(3):339-44. PubMed ID: 12639159
    [Abstract] [Full Text] [Related]

  • 8. Inhaled corticosteroids and mortality in COPD.
    Macie C, Wooldrage K, Manfreda J, Anthonisen NR.
    Chest; 2006 Sep 16; 130(3):640-6. PubMed ID: 16963657
    [Abstract] [Full Text] [Related]

  • 9. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B, Markham A.
    Drugs Aging; 2001 Sep 16; 18(6):441-72. PubMed ID: 11419918
    [Abstract] [Full Text] [Related]

  • 10. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM.
    Clin Ther; 2007 Jun 16; 29(6):1203-13. PubMed ID: 17692734
    [Abstract] [Full Text] [Related]

  • 11. Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study.
    Adimadhyam S, Schumock GT, Walton S, Joo M, McKell J, Lee TA.
    Pharmacotherapy; 2014 Jun 16; 34(4):315-23. PubMed ID: 23918239
    [Abstract] [Full Text] [Related]

  • 12. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.
    Am J Geriatr Pharmacother; 2009 Oct 16; 7(5):262-70. PubMed ID: 19948302
    [Abstract] [Full Text] [Related]

  • 13. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study.
    Wang MT, Tsai CL, Lo YW, Liou JT, Lee WJ, Lai IC.
    Int J Cardiol; 2012 Jul 12; 158(2):279-84. PubMed ID: 22386700
    [Abstract] [Full Text] [Related]

  • 14. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
    van Noord JA, Bantje TA, Eland ME, Korducki L, Cornelissen PJ.
    Thorax; 2000 Apr 12; 55(4):289-94. PubMed ID: 10722768
    [Abstract] [Full Text] [Related]

  • 15. Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United States.
    Kumbhare S, Strange C.
    South Med J; 2018 May 12; 111(5):293-298. PubMed ID: 29767222
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular events associated with ipratropium bromide in COPD.
    Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD.
    Chest; 2010 Jan 12; 137(1):13-9. PubMed ID: 19363211
    [Abstract] [Full Text] [Related]

  • 17. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group.
    Kerstjens HA, Brand PL, de Jong PM, Koëter GH, Postma DS.
    Thorax; 1994 Nov 12; 49(11):1109-15. PubMed ID: 7831626
    [Abstract] [Full Text] [Related]

  • 18. Comparative effectiveness of tiotropium and ipratropium in prevention of hospital readmission for COPD: a population-based cohort study.
    Kawasumi Y, Paterson MJ, Morrow RL, Miller TA, Bassett K, Wright JM, Dormuth CR.
    Clin Ther; 2013 Apr 12; 35(4):523-531.e1. PubMed ID: 23490290
    [Abstract] [Full Text] [Related]

  • 19. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B, Ducharme FM.
    Cochrane Database Syst Rev; 2013 Aug 21; (8):CD000060. PubMed ID: 23966133
    [Abstract] [Full Text] [Related]

  • 20. Ipratropium bromide in acute asthma.
    Ward MJ, Fentem PH, Smith WH, Davies D.
    Br Med J (Clin Res Ed); 1981 Feb 21; 282(6264):598-600. PubMed ID: 6451257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.